Olympus Biotech, an Olympus Corp. company, has announced the appointment of Oliver Burckhardt to the position of president of Olympus Biotech Corp.
Mr. Burckhardt will lead the company's North American business and focus on expanding opportunities for the regenerative medicine market, according to a company news release. He will also become a member of the Olympus Biotech board of directors.
Prior to this position, Mr. Burckhardt most recently served as the international president and CEO of Scient'x Corp in Paris, France. He has also served as president of Orthofix and spent nine years with Aesculap.
"With nearly 20 years in the medical device industry, Oliver's extensive knowledge of the industry and global leadership experience will prove invaluable as we continue to grow Olympus Biotech," said Hitoshi Mizuno, CEO of Olympus Biotech Corp., in the release. "We look forward to benefiting from his immense expertise as we continue to lead the creation of this dynamic new field of medicine."
Learn about Olympus Biotech Corporation.
More Articles Featuring Olympus:
5 Things to Know Before Buying Pre-Owned Equipment
Olympus ScopeGuide Receives FDA Clearance
Olympus Names First President of Olympus Corporation of the Americas' Medical Systems Group